rs2278651 — SLC30A1 ZnT1 variant

SLC30A1 rs2278651 — ZnT1 Zinc Efflux and Cellular Zinc Balance

Zinc is not simply a passive micronutrient. It functions as a catalytic cofactor in more than 300 enzymes, a structural component of over 1,000 zinc-finger proteins, and a dynamic signaling ion — shifting rapidly between cellular compartments to coordinate immune responses, DNA repair, insulin crystallization, and antioxidant defense. The cell's ability to manage these zinc fluxes depends critically on a family of zinc transporters¹¹ zinc transporters
SLC30A (ZnT) family: 10 members that export zinc from the cytoplasm into organelles or across the plasma membrane to the extracellular space, of which ZnT1 encoded by SLC30A1 is the most ubiquitously expressed and the only one localized exclusively to the plasma membrane.

rs2278651 is an intronic variant at position 211,577,718 on chromosome 1 (GRCh38), located 273 nucleotides downstream of exon 4 in the SLC30A1 transcript (c.622+273T>G on the coding strand; A>G on the plus strand). The variant is not in ClinVar and carries no published phenotypic association in the GWAS Catalog, placing it in the emerging evidence tier. The minor A allele (the GRCh38 reference) occurs at roughly 38% globally and up to 45% in Europeans — common enough that the heterozygote genotype (AG) is the single most frequent genotype in most populations (~47%). The biological plausibility for functional impact rests on the well-characterized biology of ZnT1 in tissues where zinc balance matters most.

The Mechanism

ZnT1 is the primary route by which cytosolic zinc exits the cell across the plasma membrane. When ZnT1 function or expression is reduced, free zinc accumulates in the cytosol. This accumulation triggers compensatory upregulation of metallothioneins²² metallothioneins
Cysteine-rich zinc-binding proteins that sequester free zinc; act as a cytosolic zinc buffer but also suppress NF-κB and nitric oxide signaling when overloaded, which paradoxically blunts immune signaling and antioxidant responses rather than protecting the cell.

Because rs2278651 is intronic, it does not alter the ZnT1 protein sequence directly. Intronic variants can, however, influence gene expression through splicing regulatory elements, transcription factor binding sites embedded in deep intronic sequence, or chromatin accessibility changes. None of these mechanisms have been experimentally validated for rs2278651 specifically — the functional link, if any, remains mechanistically uncharacterized.

SLC30A1 expression is tightly regulated by zinc availability: ZnT1 protein increases when intracellular zinc rises (protecting against toxicity) and decreases when zinc is depleted (conserving intracellular zinc). A variant that disrupts this feedback-responsive expression could therefore blunt the cell's dynamic range for zinc management without producing a fixed change detectable in standard blood work.

The Evidence

The most informative functional data for SLC30A1 in human-relevant contexts comes from conditional knockout models and immune cell studies rather than from population genetics:

Cao et al. 2024 (eLife)³³ Cao et al. 2024 (eLife)
The zinc transporter Slc30a1 (ZnT1) in macrophages plays a protective role against attenuated Salmonella. eLife demonstrated that macrophage-specific deletion of SLC30A1 in mice impaired intracellular bacterial killing, reduced NF-κB activation, and decreased inducible nitric oxide synthase (iNOS) production — the primary effector mechanism macrophages use against intracellular pathogens. The defect was attributable to aberrant intracellular zinc accumulation suppressing immune signaling, not to insufficient zinc delivery to the pathogen.

Lehmann et al. 2021 (J Leukocyte Biology)⁴⁴ Lehmann et al. 2021 (J Leukocyte Biology)
LPS-inducible SLC30A1 drives human macrophage-mediated zinc toxicity against intracellular E. coli. J Leukocyte Biol showed that in primary human macrophages, SLC30A1 is constitutively expressed but strongly upregulated by LPS stimulation. ZnT1-mediated zinc flux contributes to zinc-mediated bactericidal activity — a mechanism that depends on regulated, not constitutive, transporter expression.

Jenkitkasemwong et al. 2009 (J Nutr)⁵⁵ Jenkitkasemwong et al. 2009 (J Nutr)
Zinc transporters ZnT1, Zip8, and Zip10 in mouse red blood cells are differentially regulated during erythroid development and by dietary zinc deficiency. J Nutr showed that ZnT1 protein increases 2.3-fold during EPO-driven erythroid differentiation and decreases significantly in zinc-deficient mice, coupling ZnT1 expression to both erythropoietic demand and dietary zinc supply.

Nanba et al. 2023 (Nature Genetics)⁶⁶ Nanba et al. 2023 (Nature Genetics)
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. Nat Genet characterized in-frame deletions near the SLC30A1 zinc-binding domain that convert ZnT1 into an aberrant sodium channel, confirming that ZnT1 ion selectivity at transmembrane domain II is functionally essential. These are somatic tumor mutations, not germline variants, but they establish the mechanistic sensitivity of this transporter to structural disruption.

Practical Actions

For individuals carrying one or two A alleles at rs2278651, the most directly actionable step is ensuring dietary zinc is adequate and optimally absorbed. ZnT1 expression responds to zinc supply: when intake is sufficient, cells can up-regulate ZnT1 to clear excess cytosolic zinc efficiently. When dietary zinc is borderline, any intrinsic baseline reduction in ZnT1 expression may be compounded by reduced substrate availability.

Dietary sources with high zinc bioavailability include oysters (highest per serving), red meat, shellfish, and dairy. Plant-based sources contain zinc but also phytates that inhibit absorption — vegans and vegetarians consistently show lower serum zinc than omnivores on equivalent intakes. Soaking and fermenting legumes reduces phytate content and improves zinc bioavailability.

Monitoring serum zinc is reasonable for AA homozygotes, though a single serum zinc measurement has limitations (it reflects circulating rather than intracellular zinc, and normal reference ranges do not capture functional adequacy at the cellular level).

Interactions

SLC30A1 is one of ten SLC30A family members. rs2278651 exists in the same gene as the other SLC30A1 candidate variant rs11277 (3′ UTR). If both variants are present, their combined effect on ZnT1 expression is unknown but may be additive given they act on the same gene through potentially independent regulatory elements.

ZnT8 (SLC30A8), encoded by a separate gene, transports zinc into insulin secretory granules in pancreatic beta cells. Common SLC30A8 variants (rs13266634) affecting insulin-zinc crystallization interact with dietary zinc status in ways that parallel SLC30A1's role in cellular zinc export. Individuals carrying risk alleles at both loci may benefit most from optimizing zinc bioavailability.